Strides Pharma Science gains on receiving EIR for its US facility
20 Jan 2020

Strides Pharma Science rose 0.98% at Rs 390 after the company announced successful closure of the US drug regulator's inspection at its manufacturing site in Florida, United States.

https://www.business-standard.com/article/news-cm/strides-pharma-science-gains-on-receiving-eir-for-its-us-facility-120012000461_1.html